Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Merck's digital health accelerator expands into Africa

Will run new startup support programme in Nairobi

Merck KGaA digital health accelerator 

Merck has expanded its digital health accelerator programme, opening it up in the first country outside its home territory of Germany.

The company has picked Kenya for the new programme, which will run for three months and see it look for three digital health startups to support with equity-free funding of $15,000.

Merck Innovation Center head Michael Gamber said: “Africa is one of the most promising and dynamic markets for digital health, driven by a vibrant and innovative startup culture. With our accelerator programme, we aim to become part of it. 

“With our programme in Nairobi and our growing international network, we made a first big step to go truly global with our accelerator. We want to create a platform where the potential to execute ideas is not limited by location.”

In addition to funding, those selected to take part in the programme will also be able to make use of working space at co-working tech hub the Nairobi Garage and coaches and mentors from Merck's global network.

Merck has also opened the second round of its three-month accelerator programme. Graduates from its 2015 scheme included digital pharmacy app Apoly, which provides pharmaceutical advice and a medication delivery service.

The programme's next round comes with equity-free funding of €25,000, regular coaching and office space at the Merck Innovation Center at its Darmstadt headquarters.

The company said the two programmes would be “strongly connected in terms of expertise and knowledge exchange to grow a global accelerator network”.

“Coming from a global company we also want to develop our accelerator programme to become a global platform. The execution of an idea should not be limited by the conditions of the location where it was born,” said Gamber.

There's a growing trend for pharma firms, and other less traditional health players, to look for digital health companies to support and potentially partner with. 

One of the first was Bayer with its Grants4Apps programme, with Merck Sharp & Dohme - via its Velocity Health collaboration - and Microsoft among those also active in this area.

3rd February 2016

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....